The purpose of this study is to determine if systemic cooling to a target temperature of 34 to 35°C, started within six hours of symptom onset and maintained for 24 hours, improves functional outcome at three months in patients with acute ischaemic stroke.
Disease: Acute ischaemic stroke
Study phase: III
ECRIN support role: Monitoring
Study/trial status: Recruitment/follow-up
Expected patient number: 800 patients
Sponsor: University of Erlangen-Nurnberg Medical School
Sponsor type: Academic
Principal investigator (PI): Stefan Schwab
Current participating countries: Belgium, Bulgaria, Croatia, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Romania, Spain, Sweden, Turkey, United Kingdom
Trial identifier(s): NCT NCT01833312